Quince Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Quince Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q2 2024.
  • Quince Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 43.3M shares, a 19.1% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 43.3M +6.95M +19.1% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 43.2M +6.94M +19.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 43M +6.84M +18.9% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 36.3M +213K +0.59% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 36.3M +350K +0.97% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 36.3M +6.13M +20.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 36.1M +6.06M +20.2% Dec 31, 2022 10-K 2024-04-01
Q3 2022 36.1M +6.26M +21% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 36M +6.32M +21.3% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 30.1M +574K +1.94% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 30.1M +531K +1.8% Dec 31, 2021 10-K 2023-03-15
Q3 2021 29.9M +373K +1.27% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 29.7M +170K +0.58% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 29.6M +171K +0.58% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 29.5M +2.67M +9.95% Dec 31, 2020 10-K 2022-03-01
Q3 2020 29.5M +2.65M +9.88% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 29.5M +2.65M +9.86% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 29.4M +25.8M +724% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 26.9M +23.5M +687% Dec 31, 2019 10-K 2021-03-01
Q3 2019 26.8M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 26.8M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 3.57M Mar 31, 2019 10-Q 2019-06-12
Q4 2018 3.41M Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.